No significant interaction between CHRNA3/CHRNA5 and EPHX1 polymorphisms was detected in relation to either tobacco intake or COPD susceptibility, suggesting that their effects are likely independent and act through distinct biological pathways. Here, CHRNA5 is linked to chronic obstructive pulmonary disease.